Insomnia Trends and Forecast
The future of the global insomnia market looks promising with opportunities in the capsule and tablet markets. The global insomnia market is expected to reach an estimated $5.1 billion by 2030 with a CAGR of 3.6% from 2024 to 2030. The major drivers for this market are growing prevalence of different types of sleep disorders like insomnia and parasomnias, expanding insurance coverage for insomnia treatments, and increasing government initiatives to support sleep insomnia treatment.A more than 150-page report is developed to help in your business decisions. .
Insomnia by Segment
The study includes a forecast for the global insomnia by type of therapy, drug formulation, type of disease, and region.Insomnia Market by Type of Therapy [Shipment Analysis by Value from 2018 to 2030]:
- Pharmacological Therapy
- Non-Pharmacological Therapy
Insomnia Market by Drug Formulation [Shipment Analysis by Value from 2018 to 2030]:
- Capsules
- Tablets
- Others
Insomnia Market by Type of Disease [Shipment Analysis by Value from 2018 to 2030]:
- Poor Quality of Sleep
- Sleep Maintenance
- Others
Insomnia Market by Region [Shipment Analysis by Value from 2018 to 2030]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of Insomnia Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies insomnia companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the insomnia companies profiled in this report include:- Vanda Pharmaceuticals
- Neurim
- Eisai
- Purdue Pharma
- Merck
- Pfizer
- Astellas
- Flynn Pharma
- Takeda Pharmaceutical
- SkyePharma
Insomnia Market Insights
The publisher forecasts that non-pharmacological therapy will remain the larger segment over the forecast period due to advances in nonpharmacologic sleep therapy along with the launch of new products.Within this market, capsule is expected to witness the highest growth due to high number of product approvals and product development activities.
North America will remain the largest region over the forecast period due to growing incidence of sleep disorders increased awareness and rising healthcare spending in the region.
Features of the Global Insomnia Market
- Market Size Estimates: Insomnia market size estimation in terms of value ($B).
- Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
- Segmentation Analysis: Insomnia market size by type of therapy, drug formulation, type of disease, and region in terms of value ($B).
- Regional Analysis: Insomnia market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
- Growth Opportunities: Analysis of growth opportunities in different type of therapy, drug formulations, type of disease, and regions for the insomnia market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape of the insomnia market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQs
Q1. What is the insomnia market size?Answer: The global insomnia market is expected to reach an estimated $5.1 billion by 2030.
Q2. What is the growth forecast for insomnia market?
Answer: The global insomnia market is expected to grow with a CAGR of 3.6% from 2024 to 2030.
Q3. What are the major drivers influencing the growth of the insomnia market?
Answer: The major drivers for this market are growing prevalence of different types of sleep disorders like insomnia and parasomnias, expanding insurance coverage for insomnia treatments, and increasing government initiatives to support sleep insomnia treatment.
Q4. What are the major segments for insomnia market?
Answer: The future of the insomnia market looks promising with opportunities in the capsule and tablet markets.
Q5. Who are the key insomnia market companies?
Answer: Some of the key insomnia companies are as follows:
- Vanda Pharmaceuticals
- Neurim
- Eisai
- Purdue Pharma
- Merck
- Pfizer
- Astellas
- Flynn Pharma
- Takeda Pharmaceutical
- SkyePharma
Answer: The publisher forecasts that non-pharmacological therapy will remain the larger segment over the forecast period due to advances in nonpharmacologic sleep therapy along with the launch of new products.
Q7. In insomnia market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to growing incidence of sleep disorders increased awareness and rising healthcare spending in the region.
Q.8 Do we receive customization in this report?
Answer: Yes, the publisher provides 10% customization without any additional cost.
This report answers the following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the insomnia market by type of therapy (pharmacological therapy and non-pharmacological therapy), drug formulation (capsules, tablets, and others), type of disease (poor quality of sleep, sleep maintenance, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Global Insomnia Market : Market Dynamics
3. Market Trends and Forecast Analysis from 2018 to 2030
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
5. Competitor Analysis
6. Growth Opportunities and Strategic Analysis
7. Company Profiles of Leading Players
Companies Mentioned
- Vanda Pharmaceuticals
- Neurim
- Eisai
- Purdue Pharma
- Merck
- Pfizer
- Astellas
Methodology
The analyst has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets/applications and served over 1,000 clients worldwide. Each study is a culmination of four months of full-time effort performed by the analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in the market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of professionals, who have analyzed and tracked the market over the years.
Extensive research and interviews are conducted in the supply chain of the market to estimate market share, market size, trends, drivers, challenges and forecasts.
Thus, the analyst compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. The analyst then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process.
LOADING...
